These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Sensitization potential and reactogenicity of BCG with and without various doses of killed Mycobacterium leprae. Gupte MD, Anantharaman DS, De Britto RL, Vallishayee RS, Nagaraju B, Kannan S, Sengupta U. Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):340-52. PubMed ID: 1474275 [Abstract] [Full Text] [Related]
30. Bacillus Calmette-Guerin (BCG) lymphadenitis-changing trends and management. Nazir Z, Qazi SH. J Ayub Med Coll Abbottabad; 2005 Sep; 17(4):16-8. PubMed ID: 16599027 [Abstract] [Full Text] [Related]
31. Control of an outbreak of BCG complications in Gaza. Daoud W. Respirology; 2003 Sep; 8(3):376-8. PubMed ID: 12911834 [Abstract] [Full Text] [Related]
32. Increase in Lymphadenitis Cases after Shift in BCG Vaccine Strain. Kuchukhidze G, Kasradze A, Dolakidze T, Baliashvili D, Merabishvili T, Blumberg HM, Kempker RR. Emerg Infect Dis; 2015 Sep; 21(9):1677-9. PubMed ID: 26291303 [No Abstract] [Full Text] [Related]
40. [Suppurative lymphadenitis as a sequel of BCG vaccination in West Berlin (author's transl)]. Brehmer W, Falkenberg N, Hussels H, Otto HS, Preussler H, Waldschmidt J. Prax Klin Pneumol; 1977 May; 31(5):308-10. PubMed ID: 887577 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]